logo.png
  • googlePlaces
  • twitter
  • linkedin
  • Home

  • Team

  • Portfolio

  • Blog

  • Contact

  • Investors

    • MCPF I
    • MCPF II
    • Opportunity Fund
    • MCPF III
  • More

    Use tab to navigate through the menu items.

    Our Recent Posts

    enosix Announces Jeff Benson as VP of Sales

    Catalyst OrthoScience Announces Todd Wilson, PhD as Vice President of Medical Education & Training

    Real-world study of SPRINT Corroborates Published Clinical Study Results

    Archive

    • June 2022
    • May 2022
    • April 2022
    • March 2022
    • January 2022
    • December 2021
    • October 2021
    • September 2021
    • August 2021
    • June 2021
    • May 2021
    • April 2021
    • February 2021
    • January 2021
    • December 2020
    • November 2020
    • October 2020
    • July 2020
    • April 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • June 2019
    • May 2019
    • April 2019
    • March 2019
    • February 2019
    • January 2019
    • December 2018
    • November 2018
    • October 2018
    • September 2018
    • August 2018
    • July 2018
    • June 2018
    • May 2018
    • March 2018
    • February 2018
    • January 2018
    • December 2017
    • November 2017
    • October 2017
    • September 2017
    • August 2017
    • July 2017
    Catalyst OrthoScience Announces Todd Wilson, PhD as Vice President of Medical Education & Training

    Catalyst OrthoScience Announces Todd Wilson, PhD as Vice President of Medical Education & Training

    Catalyst OrthoScience, a medical device company focused on the upper extremity orthopedics market, is pleased to announce that Dr. Todd Wilson has joined Catalyst as Vice President of Medical Education and Training effective immediately. “We are excited to have an executive with Todd’s experience join our team at Catalyst OrthoScience,” said Catalyst OrthoScience CEO and President Carl O’Connell. “As we continue to grow and establish our presence as an emerging global leader
    Real-world study of SPRINT Corroborates Published Clinical Study Results

    Real-world study of SPRINT Corroborates Published Clinical Study Results

    SPR Therapeutics announced the publication of a study that evaluated the real-world impact of 60-day peripheral nerve stimulation (PNS) in the management of chronic pain. To investigate if this short-term treatment could provide long-term relief in a real-world setting, a cross-sectional survey was conducted of patients who had completed treatment at least one month prior to the survey. Some respondents had completed treatment over two years prior to the survey. Highlights o

     Follow us:

    • googlePlaces
    • twitter
    • linkedin

    Email us:

    Mutual Capital Partners

    1290 Bassett Rd  Suite #7

     Westlake, OH 44145

    MCPF@mutualcapitalpartners.com

    ©2021 by Mutual Capital Partners